These biotech companies have catalysts ahead.

An Augusta biotech company received $15 million in federal funding to expand production of a key ingredient for Tamiflu.

Apogee Therapeutics (NASDAQ: APGE) is one of the 17 biotechnology stocks with more than 50% upside. On January 25, Citi analyst Geoff Meacham maintained a Buy rating on Apogee Therapeutics ...

Over the past two calendar years, acquirers have agreed to pay more than $38 billion to purchase venture-backed companies in ...

The European Directory of Biotechnology Companies offers key market opportunities by providing access to 2,000 biotech companies and 5,000 executives. It assists in pinpointing decision-makers, ...

The directory offers vital insights into 1,000 top global pharmaceutical and biotech companies, featuring key management, business activities, and more. It aids market research, strategic planning, ...

New Members of the Strengthened Leadership Team Add Decades of Operational Execution, Pipeline Optimization and Transactional ...

Avid Bioservices Inc., a Tustin-based biotech company, agreed to go private in an $850-million deal that values the company at $1.1 billion on Nov. 6. Funds managed by GHO Capital Partners LLP and ...

This closing forms a natural continuum following the €7.6 million France 2030 i-Démo grant announced last year, and the very ...

As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year SAN FRANCISCO, CA, UNITED STATES, February 10, ...

For most students, science is limited to the lab bench — pipetting solutions and taking precise measurements to check the ...